A five-year certificate of deposit is a low-risk way to increase your savings, but the amount you can earn depends on how ...

Jessica Rendall is a reporter with experience covering a variety of health and wellness topics, including chronic disease, infectious disease, telemedicine, mental health and health technology. Emily ...

Learn about compound interest. We will look at how to determine the final value, initial value, interest rate and years needed. We will investigate problems compounded continuously, daily, weekly, ...

Mortgage interest rates have been on quite a ride since hovering near record lows in March 2020, during the height of the pandemic. Since then, however, they've changed significantly, rising to their ...

Drugmaker Eli Lilly says some copycat versions of its GLP-1 medications pose unique safety concerns — here’s what you need to know. A new study funded by Eli Lilly found that mixing compounded ...

Eli Lilly (LLY) has issued a public warning about potential safety risks associated with compounded tirzepatide mixed with vitamin B12. Lilly tested compounded products and found “significant levels ...

Compounded versions of tirzepatide (Mounjaro, Zepbound) containing vitamin B12 pose a potential safety risk to the public, Eli Lilly warned in an open letter on Thursday. Following laboratory testing, ...

The FDA is taking no prisoners as it continues its efforts to combat widespread GLP-1 drug compounding. In its latest offensive, the agency has unleashed a fresh set of 30 warning letters targeting ...

FAU economists said lingering inflation and delayed data are making the Fed cautious about cutting rates, adding uncertainty that shapes spending decisions. BOCA RATON, Fla. — Even as updated ...

U.S. mortgage rates have finally fallen below 6%. The average 30-year, fixed-rate mortgage is at 5.98% this week, according to a new report from the Federal Home Loan Mortgage Corp., commonly known as ...

If your medical practice or pharmacy compounds, prescribes, or dispenses semaglutide or tirzepatide, you may already be in the crosshairs of pharmaceutical giants Novo Nordisk and Eli Lilly.